Covered recipient · General Payments record
TATIANA VLADIMIROVNA SAMS
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$2,536.34
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,238.73 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $910.00 | 13 |
| Abbott Laboratories | $155.30 | 3 |
| Lilly USA, LLC | $121.13 | 1 |
| MannKind Corporation | $31.10 | 1 |
| Amgen Inc. | $21.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $118.93 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124884208 | CMS |
| Abbott Laboratories | $14.40 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124884204 | CMS |
| Abbott Laboratories | $21.97 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124884206 | CMS |
| Amgen Inc. | $21.20 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116083497 | CMS |
| Dexcom, Inc. | $14.50 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339935 | CMS |
| Dexcom, Inc. | $120.00 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339937 | CMS |
| Dexcom, Inc. | $3.75 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339939 | CMS |
| Dexcom, Inc. | $85.64 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339941 | CMS |
| Dexcom, Inc. | $11.43 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339943 | CMS |
| Dexcom, Inc. | $14.00 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339947 | CMS |
| Dexcom, Inc. | $55.12 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339945 | CMS |
| Dexcom, Inc. | $2.75 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339951 | CMS |
| Dexcom, Inc. | $128.01 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339949 | CMS |
| Dexcom, Inc. | $107.67 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339953 | CMS |
| Dexcom, Inc. | $97.92 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339955 | CMS |
| Dexcom, Inc. | $112.03 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339959 | CMS |
| Dexcom, Inc. | $157.18 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339957 | CMS |
| Lilly USA, LLC | $121.13 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135448757 | CMS |
| Mannkind Corporation | $31.10 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145849059 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.